In gliomas, the positive expression of ANKRD6 is associated with advanced tumor grade [39], whereas in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) is correlated with poor prognosis, advanced stages and poor differentiation [40–42]. Here, ANKRD6 is linked to neoplasm.